US2014370522A1PendingUtilityA1
Detection of protein translocation by beta-galactosidase reporter fragment complementation
Assignee: UNIV LELAND STANFORD JUNIORPriority: May 18, 2004Filed: Mar 24, 2014Published: Dec 18, 2014
Est. expiryMay 18, 2024(expired)· nominal 20-yr term from priority
G01N 2333/938G01N 33/581G01N 33/54306G01N 33/5035C12Y 302/01023G01N 33/542C12N 9/2471G01N 33/5008
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions are provided for detecting molecular translocations, particularly protein translocations within and between sub-cellular compartments, using at least two components that exhibit a localization-dependent difference in complementation activity. In particular, alpha-complementing β-galactosidase fragments are provided. These β-galactosidase reporter fragments display significantly enhanced enzymatic activity when one fragment is localized in a membrane. Methods for carrying out no-wash ELISA assays based on the reporter component system are also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method to assess intracellular translocation of a mammalian protein of interest in a cell, comprising:
(a) expressing in said cell a first fusion protein of the mammalian protein of interest fused to a β galactosidase peptide alpha fragment having an amino acid sequence according to wild-type SEQ ID NO: 1, provided that said sequence comprises a mutation changing one amino acid in said sequence between residues H31 and E41, or a truncation as shown in SEQ ID NO: 6; (b) expressing in said cell a second protein fused to a β galactosidase peptide fragment that can complement said alpha fragment to form an active β galactosidase enzyme that generates a detectable signal when said first fusion protein is translocated to allow complexing with said second fusion protein; and (c) detecting said signal produced by said active complex in said cell to assess intracellular translocation of said mammalian protein of interest.
2 . The method of claim 1 , wherein the first fusion protein comprises a high affinity fragment of β galactosidase and the intracellular translocation is between subcellular compartments and one of said subcellular compartments is a nucleus.
3 . The method of claim 1 , wherein the first fusion protein comprises a low affinity fragment of β-galactosidase and the intracellular translocation is between subcellular compartments which are cytosol and a membrane.
4 . The method of claim 1 , wherein said intracellular translocation is to a nucleus, cytoplasm, or membrane of said cell.
5 . The method of claim 1 , wherein the complexing is mediated by proximity of said first fusion protein and said second fusion protein.
6 . The method of claim 1 , wherein the complexing is mediated by binding of said first fusion protein to said second fusion protein.
7 . The method of claim 8 , wherein the complexing is mediated by affinity of said first fusion protein to said second fusion protein in the presence of a third compound of interest.
8 . The method of claim 7 , wherein said third compound is a protein.
9 . The method of claim 1 , wherein said mutation comprises a H31R mutation.
10 . The method of claim 1 , wherein said first fusion protein comprises is SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 9.
11 . The method of claim 1 , wherein said second fusion protein comprises SEQ ID NO: 7.
12 . The method of claim 1 , wherein said second fusion protein comprises a peptide that localizes in a membrane or an in intracellular compartment.
13 . The method of claim 12 , wherein said peptide is a triplet SV40 nuclear localization signal.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.